GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB) » Definitions » Days Payable

Nuvation Bio (Nuvation Bio) Days Payable : 0.00 (As of Sep. 2021)


View and export this data going back to 2020. Start your Free Trial

What is Nuvation Bio Days Payable?

Nuvation Bio's average Accounts Payable for the three months ended in Sep. 2021 was $4.83 Mil. Nuvation Bio's Cost of Goods Sold for the three months ended in Sep. 2021 was $0.00 Mil.

The historical rank and industry rank for Nuvation Bio's Days Payable or its related term are showing as below:

NUVB's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 147.95
* Ranked among companies with meaningful Days Payable only.

Nuvation Bio's Days Payable stayed the same from Sep. 2020 (0.00) to Sep. 2021 (0.00). stayed the same


Nuvation Bio Days Payable Historical Data

The historical data trend for Nuvation Bio's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuvation Bio Days Payable Chart

Nuvation Bio Annual Data
Trend Dec20 Dec21
Days Payable
- -

Nuvation Bio Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Days Payable Get a 7-Day Free Trial - - - - -

Competitive Comparison of Nuvation Bio's Days Payable

For the Biotechnology subindustry, Nuvation Bio's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nuvation Bio's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nuvation Bio's Days Payable distribution charts can be found below:

* The bar in red indicates where Nuvation Bio's Days Payable falls into.



Nuvation Bio Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Nuvation Bio's Days Payable for the fiscal year that ended in Dec. 2020 is calculated as

Days Payable (A: Dec. 2020 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: . 20 ) + Accounts Payable (A: Dec. 2020 )) / count ) / Cost of Goods Sold (A: Dec. 2020 )*Days in Period
=( ( + 2.7) / 1 ) / 0*365
=2.7 / 0*365
=N/A

Nuvation Bio's Days Payable for the quarter that ended in Sep. 2021 is calculated as:

Days Payable (Q: Sep. 2021 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2021 ) + Accounts Payable (Q: Sep. 2021 )) / count ) / Cost of Goods Sold (Q: Sep. 2021 )*Days in Period
=( (4.497 + 5.163) / 2 ) / 0*365 / 4
=4.83 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nuvation Bio Days Payable Related Terms

Thank you for viewing the detailed overview of Nuvation Bio's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuvation Bio (Nuvation Bio) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
1500 Broadway, Suite 1401, New York, NY, USA, 10036
Nuvation Bio Inc is a biopharmaceutical company. The company is engaged in developing therapeutic candidates for the unmet needs in oncology. The firm operates in pharmaceutical, biotechnology and other related markets that develop small molecules and drug conjugates as treatments for cancer patients.